Paydirt
NXTC
Ticker

NextCure, Inc.

NXTC · Healthcare · NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer

NextCure, Inc. (NXTC), in the Healthcare sector, has 2 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 1 purchase and 1 sale. Filers took a median of 3 days from execution to disclosure, and the most recent trade was executed Aug 10 and filed Aug 12. The most active filer was ADAR1 Capital Management, LLC with 1 filing. Data as of Nov 8 2026.

Add to watchlist
Filings, ttm
2
1 buy · 1 sell
Traders, ttm
2
2 insiders
Volume, ttmiDollar value disclosed in the window
$1.8M
estimated for Congress, as filed for insiders
Median delay
3d
execution to disclosure
Last traded
Aug 10
Filed Aug 12
ADViAverage daily dollar volume
$9.4M
market data
Share price · 12M
$5.89 (-30.7%)
$14.27$7.94$1.60Nov 10 2025Apr 2Aug 24

Adjusted for splits and dividends.

Volume by month
$1.6M$785K$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2026 · buys $1.6MAug 2026 · sells $185K
Buys $1.6M Sells $185K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed · past 24 months
AL ADAR1 Capital Management, LLC 10% owner 1 filing · 1 buy, 0 sales SI Simcere Zaiming, Inc. Other 1 filing · 0 buys, 1 sale
Recent filings
Simcere Zaiming, Inc.SALE Other $185K
30,000 sh × $6.16
Exec Aug 10
Filed Aug 12 · 11:35 AM ET ADAR1 Capital Management, LLCPURCHASE 10% owner $1.6M
317,850 sh across 7 lots
Exec Jul 30
Filed Aug 3 · 5:53 PM ET